Abstract

BackgroundTuberous sclerosis complex (TSC) is an autosomal dominant genetic condition that involves abnormalities of the skin, hamartomas in the heart, brain, and kidneys, seizures, as well as TSC‐associated neuropsychiatric disorders (TAND). About 90%–95% of individuals with TSC will have an identifiable pathogenic variant in either TSC1 or TSC2. We present here two family members with clinical diagnoses of TSC that were later determined to be due to two different genetic etiologies.MethodsA 2‐year‐old Caucasian female (Patient 1) was born to non‐consanguineous healthy parents and was determined to have a clinical diagnosis of TSC at 2 months old. Her paternal great‐uncle (Patient 2) was also known to have a clinical diagnosis of TSC. Sequencing and deletion/duplication analysis for TSC1 and TSC2 were performed on both individuals.ResultsMutation analysis revealed that both Patient 1 and Patient 2 had identifiable pathogenic variants in TSC2. Patient 1 had c.4800_4801delTG (p.Cys1600Trpfs*2), while Patient 2 had c.4470_4471delinsTT (p.Glu1490_Lys1491delinsAsp*).ConclusionTo our knowledge, our clinical report is of significance as it is the third kindred to be identified with affected members with two distinct genetic etiologies for TSC. Our case report highlights the importance of incorporating genetic testing into the clinical evaluation for individuals with features suggestive of TSC.

Highlights

  • Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder that involves abnormalities of the skin, hamartomas in the heart, brain, and kidneys, seizures, as well as TSC-associated neuropsychiatric disorders (TAND)

  • The genetic etiology of TSC stems from heterozygous pathogenic variants in TSC1 (MIM: 605284) or TSC2 (MIM: 191092) that encode for the proteins, hamartin and tuberin, respectively (European Chromosome 16 Tuberous Sclerosis Consortium, 1993; van Slegtenhorst et al, 1997)

  • Our case report highlights the importance of incorporating genetic testing into the clinical evaluation for individuals with features suggestive of TSC

Read more

Summary

Introduction

Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder that involves abnormalities of the skin, hamartomas in the heart, brain, and kidneys, seizures, as well as TSC-associated neuropsychiatric disorders (TAND). An individual can receive a diagnosis of TSC based on meeting clinical criteria and/or molecular genetic testing that identifies a pathogenic variant in either TSC1 or TSC2 (Northrup et al, 2013). The benefit of genetic testing is the opportunity to perform family studies in order to differentiate between de novo or inherited cases.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.